Navigation Links
Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
Date:10/14/2008

MOUNTAIN VIEW, Calif., Oct. 14 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., applauds the three winners of the 2008 Nobel Prize in Chemistry; Drs. Osamu Shimomura, Martin Chalfie, and Roger Y. Tsien, for the discovery and development of the green fluorescent protein (GFP) and a wide array of related fluorescent proteins. The application of fluorescent proteins as a research tool has revolutionized life science research and biotechnology: they enable researchers to monitor cellular activity in real time, characterize gene expression, and localize specific proteins, organelles, or cells of interest. Thus, fluorescent proteins have facilitated many groundbreaking discoveries in cell biology over the past decade.

"As a long-standing leader in the fluorescent protein field, Clontech is proud to have been the first company to commercialize the GFP technology that was developed by Dr. Chalfie and Dr. Douglas Prasher, enabling GFP to be used as a tool for cell biology research. Currently, we offer many fluorescent proteins that build upon the work of these three exceptional scientists, including the Fruit Fluorescent Proteins developed by Dr. Tsien," said Carol Lou, General Manager of Clontech Laboratories, Inc.

GFP was initially discovered and characterized by Dr. Shimomura, who isolated it from the jellyfish Aequorea victoria and discovered that it glowed bright green under ultraviolet light. Dr. Chalfie applied GFP to biological research, using it as a visual genetic tag to study biological phenomena in the bacterium Escherichia coli and the model organism Caenorhabditis elegans. Dr. Roger Y. Tsien, a Howard Hughes Medical Institute Investigator of the University of California, San Diego, furthered our general understanding of how GFP fluoresces and has engineered many fluorescent proteins, spanning a wide spectrum of colors not found in nature. The use of these different colored variants has enabled scien
'/>"/>

SOURCE Clontech Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
2. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
3. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
4. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
5. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
6. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
7. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
8. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
9. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
10. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
11. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email: